Objective: To determine whether an association exists between antenatal antibiotic exposure and incidence of necrotizing enterocolitis (NEC) in low birth weight infants.
Introduction
Necrotizing enterocolitis (NEC) is the most common intestinal emergency in premature infants and is a potentially devastating illness. Mucosal injury, with areas of hemorrhage, edema and coagulation necrosis that can progress to transmural perforation and clinical peritonitis, occurs most commonly in the distal ileum and ascending colon. 1 The incidence of NEC varies considerably between neonatal intensive care units, with an overall incidence of 5 to 10% for very low birth weight (BW) infants. 2, 3 The clinical presentation of NEC can be subtle or fulminant, with a mortality rate as high as 50%. 2, 4 The disparity of illness severity among patients of similar gestational age (GA) and BW is not understood.
Although much has been learned about the pathogenesis of NEC over the past 40 years, unresolved issues persist. Prematurity remains the only clearly identified risk factor for NEC. 5 Suggested pathophysiological mechanisms for NEC (alone or in combination) include enteral feedings superimposed upon immature intestinal function, increased intestinal oxygen demand required for nutrient absorption, activation of cytokine-induced inflammatory cascades, and abnormal microbial colonization and proliferation. 4, [6] [7] [8] [9] [10] The neonatal microbiota is influenced by exposure to maternal vaginal and gastrointestinal flora. 9, 11, 12 Maternal treatment with broad-spectrum antibiotics can have an impact on the biodiversity of the newborn's postnatal microbial flora. 13 In the preterm neonate, abnormal microbial colonization has been hypothesized to place the infant at increased risk for NEC. 9,14 -17 Maternal antibiotic administration as part of the antenatal management of pregnancy complications that result in preterm birth, including unexplained preterm labor (PTL), preterm premature rupture of membranes (PPROM) and clinical chorioamnionitis, is a common clinical practice. [18] [19] [20] There is no consensus in the literature regarding the risk of NEC associated with antenatal maternal antibiotic administration. Two reports suggest an association between antenatal exposure to oral amoxicillin/clavulanate and the subsequent development of NEC. 21, 22 Other investigators have not found such an association, or have found an association between antenatal antibiotic administration and reduced incidence of NEC. 19, 23, 24 We performed a retrospective, case-controlled study of newborns with NEC born at our institution between 1988 and 2006 to test the hypothesis that antenatal antibiotic exposure is associated with a greater risk of NEC.
Methods
The study was approved by the Program for Protection of Human Subjects at the Mount Sinai School of Medicine. All inborn admissions to the neonatal intensive care unit from 1988 to 2006 with a coding diagnosis of NEC were identifed from the Mount Sinai neonatal database system as potential subjects. An infant was included in the study if review of the medical record confirmed NEC disease Xstage IIA by modified Bell staging criteria. 1 Infants with NEC were matched for GA, BW, year of birth and singleton vs multiple gestation to infants without a diagnosis of NEC. Outborn infants, infants with suspected NEC (Bell stage I) and infants with isolated spontaneous bowel perforations were excluded.
Medical records for mothers of infants with and without NEC were reviewed and abstracted for relevant demographic information, as well as past medical, social and obstetric history (including PTL, PPROM, group B streptococcal status, clinical chorioamnionitis, hypertensive diseases of pregnancy including preeclampsia, and receipt of antenatal steroids). All antibiotics administered to the mother during the peripartum hospitalization (including choice of antibiotic, dose and dosing interval) were recorded. PTL was defined as progressive cervical dilation with regular uterine contractions and intact membranes. 25 PPROM was defined as the presence of vaginal pooling with either documented nitrazine-positive testing or ferning prior to regular uterine activity. 25 Clinical criteria used to make the diagnosis of chorioamnionitis included maternal fever, maternal and fetal tachycardia, uterine tenderness and foul-smelling amniotic fluid. 20 Preeclampsia was defined as new onset hypertension and proteinuria of sufficient severity to warrant delivery for either a maternal or fetal indication. 25 Medical records for infants with and without NEC were reviewed and abstracted for clinical information including GA, BW, gender, Apgar scores, survival to hospital discharge, composition of enteral feeds, presence of hyaline membrane disease, diagnosis of patent ductus arteriosus, small for GA, and receipt of postnatal steroids. Hyaline membrane disease was defined as respiratory distress in infants <37 weeks GA, with a requirement for >40% oxygen in conjunction with a reticulogranular pattern on chest radiograph. Small for GA was defined as anthropomorphic measurements <10% for GA as assessed on admission physical exam. 26 Clinical characteristics of neonates who developed NEC and their mothers were compared with control infants and their mothers by McNemar's test for dichotomous variables and by paired t-test for continuous variables. Significance was defined as P<0.05. The Mantel-Haenszel odds ratios (ORs) (95% confidence interval (CI)) for exposure to antenatal antibiotics were calculated for each NEC-control pair. Based on initial results, any antenatal ampicillin treatment was used as the exposure variable in all subsequent analyses. Potential confounders with P<0.3 by McNemar's test were included in multivariable conditional logistic regression models. All confounders were included as potential effect modifiers in the initial model, but were excluded as insignificant by likelihood ratio Chi-square P>0.05. Results are given as number (percentage), mean (s.d.) or the adjusted OR (95% CI). All statistical analyses were performed with PASW Statistics 18 (SPSS, Armonk, NY, USA).
Results
One hundred and sixty-three inborn infants with a coding diagnosis of NEC were born at our institution between 1 January 1988 and 31 December 2006. Sixteen infants were excluded because of incomplete medical records. Another 50 infants were excluded after review of the medical records revealed that they either did not have NEC (n ¼ 2) or had only stage I disease (n ¼ 48). The remaining 97 infants with NEC Xstage IIA were matched for GA (NEC 29.1 ± 4.0 weeks; control 29.3 ± 3.9 weeks), BW (NEC 1342±639 g; control 1347±632 g), year of birth and singleton vs multiple gestation with infants without a diagnosis of NEC, and comprised the study population. Medical characteristics of the study population are presented in Table 1 . Infants who developed NEC were more likely to have a history of antenatal antibiotic exposure than those who did not (OR 2.0, 95% CI (1.0, 3.9), P ¼ 0.04). Mothers in the study population received a variety of antenatal antibiotics either as monotherapy or in combination. Estimates of the relative odds of an infant developing NEC with antenatal antibiotic exposure are presented in Table 2 . Infants who developed NEC were more likely to have been exposed to ampicillin (alone or in combination with other antibiotics) as part of antepartum management than infants who did not develop NEC (unadjusted OR 2.8, 95% CI (1.4, 5.8), P<0.005). Antenatal exposure to clindamycin, gentamicin, ampicillin-sulbactam, cefazolin, piperacillin or erythromycin did not differ between the NEC group and the control group.
Based on unadjusted ORs of antepartum antibiotic regimens, a logistic regression model was constructed with antepartum ampicillin exposure, alone or in combination with other antibiotics, as the exposure variable. Clinically relevant potential confounding variables, including use of any assisted reproductive technology for conception, mode of delivery, singleton vs multiple gestation, small for GA, PPROM, PTL, lack of antenatal steroid administration, GA, BW, Apgar scores, hyaline membrane disease, patent ductus arteriosus and neonatal hypotension, were not significantly diffferent between the NEC and control groups, and therefore were not used in construction of the logistic regression model. The presence of any maternal hypertension (including preeclampsia), clinical chorioamnionitis, exposure of the newborn to any formula feeding, male gender and neonatal pressor use during the first week of life were significantly different between the groups and were included in the initial logistic regression model (Table 3) . Antenatal ampicillin exposure resulted in significantly increased risk of developing NEC (OR 2.3, CI (1.0, 5.2), P<0.002).
In the most parsimonious model, the OR of an infant developing NEC with antenatal ampicillin exposure, adjusted for only maternal hypertensive disorders and chorioamnionitis, was 2.3 (CI (1.1, 4.8), P<0.003).
Discussion
In this retrospective case-control study, we demonstrated that preterm infants who developed NEC were more likely to have been exposed to an antepartum antibiotic regimen that included ampicillin than infants who did not develop NEC. No association was found between NEC and antepartum exposure to antibiotics other than ampicillin. The results of previous reports describing the risk of NEC in association with maternal antibiotic administration have been contradictory. The ORACLE trials suggested an association between administration of oral amoxicillin/clavulanate to women with PPROM or spontaneous PTL and the subsequent development of NEC in their infants. 21, 22 In contrast, in a casecontrol chart review spanning a 17-year study period, Al-Sabbagh et al. 23 found no evidence of an association betweeen antenatal exposure to amoxicilllin/clavulanate and the later development of 1.00 8 8
Abbreviations: CI, confidence interval; NEC, necrotizing enterocolitis; OR, odds ratio. a Mantel-Haenszel odds ratio for antepartum antibiotic exposure was calculated for NEC-control pairs. b Antibiotic used as monotherapy.
c Antibiotic used as single agent or in combination with other antibiotics. * Significant at P<0.05. NEC. Similarly, Ehsanipoor et al. 24 found no association between antenatal administration of ampicillin-sulbactam/amoxicillinclavulanate to women with PPROM and the subsequent development of NEC in their infants. Mercer et al., 19, 27 however, showed that aggressive antenatal antibiotic treatment was associated with a reduction in NEC.
Why might antepartum antibiotic exposure set the stage for NEC weeks later? Although the fetal gastrointestinal tract is believed to be sterile, a fetus is exposed to maternal gastrointestinal and genitourinary flora when microbes invade the amniotic cavity in the setting of PPROM or PTL, and with passage through the birth canal during delivery. [28] [29] [30] As neonatal intestinal microflora is acquired from the environment, the diversity of neonatal microflora is influenced by many antenatal and postnatal factors, including mode of delivery, GA, composition of enteral feeding (human milk vs formula) and antibiotic exposure. 9,11 -13,31 It follows that the spectrum of antibiotic exposure in the antepartum period can alter the pattern of newborn intestinal flora.
Healthy, full-term, breast-fed newborns have a predominance of bifidobacterial flora, whereas the microbiota of sick preterm infants has less bacterial diversity. 15, 17, 32 A narrowing spectrum of microflora presages the development of NEC. 15 Wang et al.
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demonstrated that preterm infants with NEC had a predominance of proteobacteria in the stool, and suggested that limited bacterial diversity and pathogenic bacterial predominance may contribute to the susceptibiity of premature infants to NEC. During the 18-year period encompassed by our study, patterns of perinatal antibiotic use have changed dramatically. Throughout this period, though, ampicillin has been widely used, alone and in combination with sulbactam or erythromycin, in the management of PPROM and clinical chorioamnionitis and as an alternative to penicillin for group B streptococcal chemoprophylaxis. [18] [19] [20] Given the widespread use of ampicillin in these clinical contexts, the association of antepartum ampicillin exposure with NEC is of great concern.
The strengths of our study were the study population itself and the means of analysis. Our study population included only subjects with confirmed NEC (Bell's stage X IIA). Both patients with stage I disease, which can be difficult to distinguish from suspected bacteremia/sepsis unrelated to the gastrointestinal system, and patients with isolated spontaneous bowel perforations were excluded from analysis. 6 Each baby with NEC was compared only with the control infant with whom she/he was matched and not with other subjects with differing levels of confounding variables (for example, GA, BW, multiplicity of gestation and year of birth).
This study has several limitations including the retrospective nature of our review, the broad time period evaluated during which obstetric antibiotic practices changed considerably and reliance on diagnoses and treatment plans initiated by treating physicians. Our use of coding diagnosis for identification of potential subjects may have failed to identify some potentially eligible subjects. Although our results showed an association between antepartum exposure to ampicillin and the subsequent diagnosis of NEC, the association does not imply causation. Finally, the most premature neonates are both at the greatest risk for NEC due to intestinal immaturity and the most likely to be exposed to antepartum antibiotic regimens containing ampicillin in an attempt to prolong latency in the face of threatened delivery.
In conclusion, preterm infants who developed NEC were more likely to have a history or antepartum ampicillin exposure than matched controls who did not develop NEC. A larger, prospective study is needed to corroborate our results. Until then, judicious use of antenatal ampicillin may be warranted.
